DOCSLIB.ORG

Proteogenomic Characterization of Patient- Derived Xenografts

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Published OnlineFirst October 1, 2018; DOI: 10.1158/1078-0432.CCR-18-0729 Precision Medicine and Imaging Clinical Cancer Research Proteogenomic Characterization of Patient- Derived Xenografts Highlights the Role of REST in Neuroendocrine Differentiation of Castration- Resistant Prostate Cancer Amilcar Flores-Morales1,2,3, Tobias B. Bergmann1,2, Charlotte Lavallee1,2, Tanveer S. Batth3, Dong Lin4, Mads Lerdrup5, Stine Friis1,2, Anette Bartels1,2, Gitte Kristensen6, Agnieszka Krzyzanowska7, Hui Xue4, Ladan Fazli4, Klaus H. Hansen5, Martin A. Røder6, Klaus Brasso6, Jose M. Moreira1,2, Anders Bjartell7, Yuzhuo Wang4, Jesper V. Olsen3, Colin C. Collins4, and Diego Iglesias-Gato1,2 Abstract Purpose: An increasing number of castration-resistant and elevated in NEPC, while the reduced levels of proteins prostate cancer (CRPC) tumors exhibit neuroendocrine (NE) involved in mitochondrial functions suggested a prevalent features. NE prostate cancer (NEPC) has poor prognosis, and glycolytic metabolism of NEPC tumors. Integration of the its development is poorly understood. REST chromatin bound regions with expression changes Experimental Design: We applied mass spectrometry– indicated a direct role of REST in regulating neuronal gene based proteomics to a unique set of 17 prostate cancer expression in prostate cancer cells. Mechanistically, deple- patient–derived xenografts (PDX) to characterize the effects tion of REST led to cell-cycle arrest in G1, which could be of castration in vivo, and the proteome differences between rescued by p53 knockdown. Finally, the expression of the NEPC and prostate adenocarcinomas. Genome-wide profiling REST-regulated gene secretagogin (SCGN) correlated with of REST-occupied regions in prostate cancer cells was corre- an increased risk of suffering disease relapse after radical lated to the expression changes in vivo to investigate the role of prostatectomy. the transcriptional repressor REST in castration-induced NEPC Conclusions: This study presents the first deep characteri- differentiation. zation of the proteome of NEPC and suggests that concom- Results: An average of 4,881 proteins were identified and itant inhibition of REST and the p53 pathway would promote quantified from each PDX. Proteins related to neurogenesis, NEPC. We also identify SCGN as a novel prognostic marker in cell-cycle regulation, and DNA repair were found upregulated prostate cancer. Introduction androgen receptor (AR) blockage and are driven by complex mechanisms that involve genetic, epigenetic, and posttranscrip- Death in prostate cancer patients mostly occurs after the devel- tional changes (1, 2). Extensive studies have been carried out to opment of castration-resistant metastatic disease (CRPC). Castra- identify tumor driving genetic alterations in CRPC, but a unified tion-resistant tumors develop after androgen ablation therapy or genetic model of disease progression is yet to emerge. Amplifi- cation of the AR gene locus or point mutations in the AR gene occurs in 60% of tumors that have been subjected to androgen 1Department of Drug Design and Pharmacology, Faculty of Health and Medical ablation therapy (3). The appearance of ligand-independent AR Sciences, University of Copenhagen, Copenhagen, Denmark. 2The Danish Can- fi 3 splice variants or AR posttranslational modi cation may also cer Society, Copenhagen, Denmark. Novo Nordisk Foundation Center for contribute to continued AR activation following castration (4). Protein Research, Faculty of Health and Medical Sciences, University of Copen- hagen, Copenhagen, Denmark. 4Vancouver Prostate Centre, University of British Other common genetic alterations in AR-expressing CRPC Columbia, Vancouver, British Columbia, Canada. 5Biotech Research and Inno- include heterozygous deletions of PTEN and, to a lesser extent, vation Center, University of Copenhagen, Copenhagen, Denmark. 6Copenhagen p53 inactivation or loss of Rb1 expression (5–8). Prostate Cancer Center, Department of Urology, Rigshospitalet, University of One recurrent cellular feature of CRPC is the presence of 7 Copenhagen, Copenhagen, Denmark. Department of Translational Medicine, carcinoma cells that exhibit a neuroendocrine phenotype. Neu- Division of Urological Cancers, Lund University, Lund, Sweden. roendocrine differentiation (NED) of prostate cells is frequently Note: Supplementary data for this article are available at Clinical Cancer associated with highly proliferative potential of tumors and Research Online (http://clincancerres.aacrjournals.org/). increased chemoresistance, and as a consequence understanding Corresponding Author: Diego Iglesias-Gato, University of Copenhagen, The the development of NED in CRCP can lead to the development of Danish Cancer Society. Strandboulevarden 49Strand, Copenhagen 2100, new therapeutic strategies for CRPC. Neuroendocrine prostate Denmark. Phone: 4535330640; Fax: 4535325001; E-mail: cancer (NEPC) constitutes a distinct class of castration-resistant [email protected] tumors characterized by the expression of neuronal markers such doi: 10.1158/1078-0432.CCR-18-0729 as Chromogranin A (CHGA), Synaptophysin (SYP), and neural Ó2018 American Association for Cancer Research. cell adhesion molecule (CD56; ref. 9). NEPCs show similarities to www.aacrjournals.org 595 Downloaded from clincancerres.aacrjournals.org on September 30, 2021. © 2019 American Association for Cancer Research. Published OnlineFirst October 1, 2018; DOI: 10.1158/1078-0432.CCR-18-0729 Flores-Morales et al. Radical prostatectomy tissue microarray Translational Relevance The study cohort is composed of a consecutive series of men The number of castration-resistant prostate tumors exhibit- (n ¼ 336) with clinically localized prostate cancer who underwent ing neuroendocrine features is increasing, due in part to the radical prostatectomy (RP) with curative intent from January 1, improvement of drugs targeting the androgen receptor. Neu- 2002, until December 31, 2005, at the Department of Urology, roendocrine prostate cancer has poor prognosis due to the Rigshospitalet, Copenhagen, Denmark. This study was approved limited efficacy of currently available therapies. In this study, by the Danish National Committee on Health Research Ethics for we provide the first deep characterization of the proteome of the Capital Region (Journal no.: H-6-2014-111). Biochemical castration-resistant neuroendocrine prostate cancer. Proteins failure (BF) was defined as PSA 0.2 mg/L. The collection of are the ultimate targets of most anticancer drugs; therefore, our data was approved by The Danish Data Protection Agency work constitutes a valuable resource for the development of (file#2006-1-6256). The validation cohort (Malmo)€ was previ- novel compounds targeting proteins with increased expression ously described (18, 21). All studies were conducted following the in these tumors. Moreover, we provide evidence that early principles of the Declaration of Helsinki. All participants gave expression of the neuron-specific protein secretagogin in early written or verbal consent. Verbal consent was documented by the stages of prostate cancer correlates with increased risk of physician in the patient journal. biochemical recurrence after radical prostatectomy and could be accounted for in patients managed with conservative pro- IHC and statistics tocols such as active surveillance. TMA sections were deparaffinized in xylene and rehydrated through graded ethanol- Antigen retrieval performed at pH6. IHC staining was performed using anti SCGN antibody (HPA006641, Sigma-Aldrich, diluted 1:250). The SCGN staining was quantified small-cell carcinoma of the prostate (SCCP), which accounts for by scoring the intensity and the percentage of stained tumor cells 0.5% to 2% of all primary prostatic malignancies (10). Patients (0 ¼ negative or positive only in scattered neuroendocrine pros- diagnosed with SCCP have poor prognosis, with a median sur- tate cells; 1 ¼ weak staining in less than 30% for the tumor cells; vival time ranging from 5 to 17.5 months and the 5-year survival 2 ¼ intense staining in less than 20% of the cells on a localized rate of 14.3% (11). Moreover, in patients with locally advanced focus; 3 ¼ moderated staining in more than 50% of the cells or tumors treated with androgen ablation therapy (alone or in a intense staining in less than 50%; 4 ¼ intense staining in more coadjuvant setting), and in patients with CRPC, the extent of NED than 50% of the cells). Of all cores obtained from the same has been shown to be an independent prognostic factor (12). specimen, the highest expression was selected. Scores 2 were The molecular mechanisms driving the development of NE considered as high SCGN expression. The association between tumors after castration therapy are yet to be fully understood. The SCGN expression and clinicopathologic variables was analyzed loss of AR expression, the identification of recurrent mutations in using c2 test or Fisher exact test for categorical variables and the tumor suppressor genes such as Rb1 and p53, and the amplifi- Mann–Whitney U test for continuous variables. The median time cation of genes such as Aurora Kinase A (AURKA) and MYCN are of follow-up was calculated using the reverse Kaplan–Meier thought to play important roles in NE transdifferentiation and the method (22). Follow-up for BF was calculated until the latest aggressiveness of prostate cancer (13–17). Additionally, we PSA measurement, whereas time to death was calculated until the recently demonstrated that inactivation of the transcriptional
Recommended publications
  • Cytotoxic Effects and Changes in Gene Expression Profile

    Cytotoxic Effects and Changes in Gene Expression Profile

    Toxicology in Vitro 34 (2016) 309–320 Contents lists available at ScienceDirect Toxicology in Vitro journal homepage: www.elsevier.com/locate/toxinvit Fusarium mycotoxin enniatin B: Cytotoxic effects and changes in gene expression profile Martina Jonsson a,⁎,MarikaJestoib, Minna Anthoni a, Annikki Welling a, Iida Loivamaa a, Ville Hallikainen c, Matti Kankainen d, Erik Lysøe e, Pertti Koivisto a, Kimmo Peltonen a,f a Chemistry and Toxicology Research Unit, Finnish Food Safety Authority (Evira), Mustialankatu 3, FI-00790 Helsinki, Finland b Product Safety Unit, Finnish Food Safety Authority (Evira), Mustialankatu 3, FI-00790 Helsinki, c The Finnish Forest Research Institute, Rovaniemi Unit, P.O. Box 16, FI-96301 Rovaniemi, Finland d Institute for Molecular Medicine Finland (FIMM), University of Helsinki, P.O. Box 20, FI-00014, Finland e Plant Health and Biotechnology, Norwegian Institute of Bioeconomy, Høyskoleveien 7, NO -1430 Ås, Norway f Finnish Safety and Chemicals Agency (Tukes), Opastinsilta 12 B, FI-00521 Helsinki, Finland article info abstract Article history: The mycotoxin enniatin B, a cyclic hexadepsipeptide produced by the plant pathogen Fusarium,isprevalentin Received 3 December 2015 grains and grain-based products in different geographical areas. Although enniatins have not been associated Received in revised form 5 April 2016 with toxic outbreaks, they have caused toxicity in vitro in several cell lines. In this study, the cytotoxic effects Accepted 28 April 2016 of enniatin B were assessed in relation to cellular energy metabolism, cell proliferation, and the induction of ap- Available online 6 May 2016 optosis in Balb 3T3 and HepG2 cells. The mechanism of toxicity was examined by means of whole genome ex- fi Keywords: pression pro ling of exposed rat primary hepatocytes.
  • Breed Relationships Facilitate Fine-Mapping Studies: a 7.8-Kb Deletion Cosegregates with Collie Eye Anomaly Across Multiple Dog Breeds

    Breed Relationships Facilitate Fine-Mapping Studies: a 7.8-Kb Deletion Cosegregates with Collie Eye Anomaly Across Multiple Dog Breeds

    Downloaded from genome.cshlp.org on October 4, 2021 - Published by Cold Spring Harbor Laboratory Press Article Breed relationships facilitate fine-mapping studies: A 7.8-kb deletion cosegregates with Collie eye anomaly across multiple dog breeds Heidi G. Parker,1 Anna V. Kukekova,2 Dayna T. Akey,3 Orly Goldstein,2 Ewen F. Kirkness,4 Kathleen C. Baysac,1 Dana S. Mosher,1 Gustavo D. Aguirre,5 Gregory M. Acland,2 and Elaine A. Ostrander1,6 1Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20892, USA; 2Baker Institute for Animal Health, College of Veterinary Medicine, Cornell University, Ithaca, New York 14853, USA; 3Department of Genome Sciences, School of Medicine, University of Washington, Seattle, Washington 98195, USA; 4The Institute for Genomic Research, Rockville, Maryland 20850, USA; 5Department of Clinical Studies, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA The features of modern dog breeds that increase the ease of mapping common diseases, such as reduced heterogeneity and extensive linkage disequilibrium, may also increase the difficulty associated with fine mapping and identifying causative mutations. One way to address this problem is by combining data from multiple breeds segregating the same trait after initial linkage has been determined. The multibreed approach increases the number of potentially informative recombination events and reduces the size of the critical haplotype by taking advantage of shortened linkage disequilibrium distances found across breeds. In order to identify breeds that likely share a trait inherited from the same ancestral source, we have used cluster analysis to divide 132 breeds of dog into five primary breed groups.
  • Targeted Pharmacological Therapy Restores Β-Cell Function for Diabetes Remission

    Targeted Pharmacological Therapy Restores Β-Cell Function for Diabetes Remission

    Targeted pharmacological therapy restores -cell function for diabetes remission Sachs, Stephan; Bastidas-Ponce, Aimée; Tritschler, Sophie; Bakhti, Mostafa; Böttcher, Anika; Sánchez-Garrido, Miguel A; Tarquis-Medina, Marta; Kleinert, Maximilian; Fischer, Katrin; Jall, Sigrid; Harger, Alexandra; Bader, Erik; Roscioni, Sara; Ussar, Siegfried; Feuchtinger, Annette; Yesildag, Burcak; Neelakandhan, Aparna; Jensen, Christine B; Cornu, Marion; Yang, Bin; Finan, Brian; DiMarchi, Richard D; Tschöp, Matthias H; Theis, Fabian J; Hofmann, Susanna M.; Müller, Timo D; Lickert, Heiko Published in: Nature Metabolism DOI: 10.1038/s42255-020-0171-3 Publication date: 2020 Document version Publisher's PDF, also known as Version of record Document license: CC BY Citation for published version (APA): Sachs, S., Bastidas-Ponce, A., Tritschler, S., Bakhti, M., Böttcher, A., Sánchez-Garrido, M. A., Tarquis-Medina, M., Kleinert, M., Fischer, K., Jall, S., Harger, A., Bader, E., Roscioni, S., Ussar, S., Feuchtinger, A., Yesildag, B., Neelakandhan, A., Jensen, C. B., Cornu, M., ... Lickert, H. (2020). Targeted pharmacological therapy restores - cell function for diabetes remission. Nature Metabolism, 2(2), 192-209. https://doi.org/10.1038/s42255-020- 0171-3 Download date: 05. Oct. 2021 ARTICLES https://doi.org/10.1038/s42255-020-0171-3 There are amendments to this paper Targeted pharmacological therapy restores β-cell function for diabetes remission Stephan Sachs1,2,3,4,19, Aimée Bastidas-Ponce1,4,5,6,19, Sophie Tritschler1,4,7,8,19, Mostafa Bakhti 1,4,5, Anika Böttcher1,4,5, Miguel A. Sánchez-Garrido2, Marta Tarquis-Medina1,4,5,6, Maximilian Kleinert2,9, Katrin Fischer2,3, Sigrid Jall2,3, Alexandra Harger2, Erik Bader1, Sara Roscioni1, Siegfried Ussar 4,6,10, Annette Feuchtinger11, Burcak Yesildag12, Aparna Neelakandhan12, Christine B.
  • Identification of Potential Key Genes and Pathway Linked with Sporadic Creutzfeldt-Jakob Disease Based on Integrated Bioinformatics Analyses

    Identification of Potential Key Genes and Pathway Linked with Sporadic Creutzfeldt-Jakob Disease Based on Integrated Bioinformatics Analyses

    medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Identification of potential key genes and pathway linked with sporadic Creutzfeldt-Jakob disease based on integrated bioinformatics analyses Basavaraj Vastrad1, Chanabasayya Vastrad*2 , Iranna Kotturshetti 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. 3. Department of Ayurveda, Rajiv Gandhi Education Society`s Ayurvedic Medical College, Ron, Karnataka 562209, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Abstract Sporadic Creutzfeldt-Jakob disease (sCJD) is neurodegenerative disease also called prion disease linked with poor prognosis. The aim of the current study was to illuminate the underlying molecular mechanisms of sCJD. The mRNA microarray dataset GSE124571 was downloaded from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) were screened.
  • CDK5 Functions As a Tumor Promoter in Human Lung Cancer Jie Zeng1#, Shuanshuan Xie1#, Yang Liu1, Changxing Shen1, Xiaolian Song1, Guo-Lei Zhou2, 3, Changhui Wang1

    CDK5 Functions As a Tumor Promoter in Human Lung Cancer Jie Zeng1#, Shuanshuan Xie1#, Yang Liu1, Changxing Shen1, Xiaolian Song1, Guo-Lei Zhou2, 3, Changhui Wang1

    Journal of Cancer 2018, Vol. 9 3950 Ivyspring International Publisher Journal of Cancer 2018; 9(21): 3950-3961. doi: 10.7150/jca.25967 Research Paper CDK5 Functions as a Tumor Promoter in Human Lung Cancer Jie Zeng1#, Shuanshuan Xie1#, Yang Liu1, Changxing Shen1, Xiaolian Song1, Guo-Lei Zhou2, 3, Changhui Wang1 1. Department of Respiratory Medicine, Shanghai Tenth People’s Hospital, Tongji University, Shanghai 200072, PR China; 2. Department of Biological Sciences, Arkansas State University, State University, AR 72467, USA; 3. Molecular Biosciences Program, Arkansas State University, State University, AR 72467, USA. # These authors have contributed equally to this work. Corresponding author: Changhui Wang, No.301, Mid Yanchang Rd, Department of Respiratory Medicine, Shanghai Tenth People’s Hospital, Tongji University, Shanghai, China, 200072. Email: [email protected], Fax number: 86-021-66301685, Telephone: 86-021-66301685 © Ivyspring International Publisher. This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions. Received: 2018.03.09; Accepted: 2018.08.19; Published: 2018.10.10 Abstract Cyclin-dependent kinase 5 (CDK5), an atypical member of the cyclin-dependent kinase family, plays an important role in the nervous system. Recent studies have shown that CDK5 is also associated with tumors. However, few studies have been done to investigate the mechanism underlying the connection between CDK5 and cancers. To explore the role of CDK5 in cancers by using an extensive bioinformatics data mining process. We mined the transcriptional, survival, functions and structure of CDK5 gene through databases and in vitro experiments.
  • Hippo and Sonic Hedgehog Signalling Pathway Modulation of Human Urothelial Tissue Homeostasis

    Hippo and Sonic Hedgehog Signalling Pathway Modulation of Human Urothelial Tissue Homeostasis

    Hippo and Sonic Hedgehog signalling pathway modulation of human urothelial tissue homeostasis Thomas Crighton PhD University of York Department of Biology November 2020 Abstract The urinary tract is lined by a barrier-forming, mitotically-quiescent urothelium, which retains the ability to regenerate following injury. Regulation of tissue homeostasis by Hippo and Sonic Hedgehog signalling has previously been implicated in various mammalian epithelia, but limited evidence exists as to their role in adult human urothelial physiology. Focussing on the Hippo pathway, the aims of this thesis were to characterise expression of said pathways in urothelium, determine what role the pathways have in regulating urothelial phenotype, and investigate whether the pathways are implicated in muscle-invasive bladder cancer (MIBC). These aims were assessed using a cell culture paradigm of Normal Human Urothelial (NHU) cells that can be manipulated in vitro to represent different differentiated phenotypes, alongside MIBC cell lines and The Cancer Genome Atlas resource. Transcriptomic analysis of NHU cells identified a significant induction of VGLL1, a poorly understood regulator of Hippo signalling, in differentiated cells. Activation of upstream transcription factors PPARγ and GATA3 and/or blockade of active EGFR/RAS/RAF/MEK/ERK signalling were identified as mechanisms which induce VGLL1 expression in NHU cells. Ectopic overexpression of VGLL1 in undifferentiated NHU cells and MIBC cell line T24 resulted in significantly reduced proliferation. Conversely, knockdown of VGLL1 in differentiated NHU cells significantly reduced barrier tightness in an unwounded state, while inhibiting regeneration and increasing cell cycle activation in scratch-wounded cultures. A signalling pathway previously observed to be inhibited by VGLL1 function, YAP/TAZ, was unaffected by VGLL1 manipulation.
  • RNA Sequencing Reveals a Diverse and Dynamic Repertoire of the Xenopus Tropicalis Transcriptome Over Development

    RNA Sequencing Reveals a Diverse and Dynamic Repertoire of the Xenopus Tropicalis Transcriptome Over Development

    Downloaded from genome.cshlp.org on October 6, 2021 - Published by Cold Spring Harbor Laboratory Press Resource RNA sequencing reveals a diverse and dynamic repertoire of the Xenopus tropicalis transcriptome over development Meng How Tan,1,6,7 Kin Fai Au,2,6 Arielle L. Yablonovitch,1,3,6 Andrea E. Wills,1 Jason Chuang,4 Julie C. Baker,1 Wing Hung Wong,2,5 and Jin Billy Li1,7 1Department of Genetics, Stanford University School of Medicine, Stanford, California 94305, USA; 2Department of Statistics, School of Humanities and Sciences, Stanford University, Stanford, California 94305, USA; 3Program in Biophysics, School of Humanities and Sciences, Stanford University, Stanford, California 94305, USA; 4Department of Computer Science, School of Engineering, Stanford University, Stanford, California 94305, USA; 5Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California 94305, USA The Xenopus embryo has provided key insights into fate specification, the cell cycle, and other fundamental developmental and cellular processes, yet a comprehensive understanding of its transcriptome is lacking. Here, we used paired end RNA sequencing (RNA-seq) to explore the transcriptome of Xenopus tropicalis in 23 distinct developmental stages. We determined expression levels of all genes annotated in RefSeq and Ensembl and showed for the first time on a genome-wide scale that, despite a general state of transcriptional silence in the earliest stages of development, approximately 150 genes are tran- scribed prior to the midblastula transition. In addition, our splicing analysis uncovered more than 10,000 novel splice junctions at each stage and revealed that many known genes have additional unannotated isoforms.
  • Gene Expression in the Brain of a Migratory Songbird During Breeding and Migration

    Gene Expression in the Brain of a Migratory Songbird During Breeding and Migration

    Boss et al. Movement Ecology (2016) 4:4 DOI 10.1186/s40462-016-0069-6 RESEARCH Open Access Gene expression in the brain of a migratory songbird during breeding and migration John Boss1,2, Miriam Liedvogel3,6, Max Lundberg3, Peter Olsson4, Nils Reischke3, Sara Naurin3, Susanne Åkesson5, Dennis Hasselquist3, Anthony Wright1, Mats Grahn1 and Staffan Bensch3* Abstract Background: We still have limited knowledge about the underlying genetic mechanisms that enable migrating species of birds to navigate the globe. Here we make an attempt to get insight into the genetic architecture controlling this complex innate behaviour. We contrast the gene expression profiles of two closely related songbird subspecies with divergent migratory phenotypes. In addition to comparing differences in migratory strategy we include a temporal component and contrast patterns between breeding adults and autumn migrating juvenile birds of both subspecies. The two willow warbler subspecies, Phylloscopus trochilus trochilus and P. t. acredula, are remarkably similar both in phenotype and genotype and have a narrow contact zone in central Scandinavia. Here we used a microarray gene chip representing 23,136 expressed sequence tags (ESTs) from the zebra finch Taeniopygia guttata to identify mRNA level differences in willow warbler brain tissue in relation to subspecies and season. Results: Out of the 22,109 EST probe sets that remained after filtering poorly binding probes, we found 11,898 (51.8 %) probe sets that could be reliably and uniquely matched to a total of 6,758 orthologous zebra finch genes. The two subspecies showed very similar levels of gene expression with less than 0.1 % of the probe sets being significantly differentially expressed.
  • Beta Cell Adaptation to Pregnancy Requires Prolactin Action on Both

    Beta Cell Adaptation to Pregnancy Requires Prolactin Action on Both

    www.nature.com/scientificreports OPEN Beta cell adaptation to pregnancy requires prolactin action on both beta and non‑beta cells Vipul Shrivastava1, Megan Lee1, Daniel Lee1, Marle Pretorius1, Bethany Radford1, Guneet Makkar1 & Carol Huang1,2,3* Pancreatic islets adapt to insulin resistance of pregnancy by up regulating β‑cell mass and increasing insulin secretion. Previously, using a transgenic mouse with global, heterozygous deletion of prolactin receptor (Prlr+/−), we found Prlr signaling is important for this adaptation. However, since Prlr is expressed in tissues outside of islets as well as within islets and prolactin signaling afects β‑cell development, to understand β‑cell‑specifc efect of prolactin signaling in pregnancy, we generated a transgenic mouse with an inducible conditional deletion of Prlr from β‑cells. Here, we found that β‑cell‑specifc Prlr reduction in adult mice led to elevated blood glucose, lowed β‑cell mass and blunted in vivo glucose‑stimulated insulin secretion during pregnancy. When we compared gene expression profle of islets from transgenic mice with global (Prlr+/−) versus β‑cell‑specifc Prlr reduction (βPrlR+/−), we found 95 diferentially expressed gene, most of them down regulated in the Prlr+/− mice in comparison to the βPrlR+/− mice, and many of these genes regulate apoptosis, synaptic vesicle function and neuronal development. Importantly, we found that islets from pregnant Prlr+/− mice are more vulnerable to glucolipotoxicity‑induced apoptosis than islets from pregnant βPrlR+/− mice. These observations suggest that down regulation of prolactin action during pregnancy in non‑β‑cells secondarily and negatively afect β‑cell gene expression, and increased β‑cell susceptibility to external insults.
  • Genome-Wide Association Studies of Smooth Pursuit and Antisaccade Eye Movements in Psychotic Disorders: findings from the B-SNIP Study

    Genome-Wide Association Studies of Smooth Pursuit and Antisaccade Eye Movements in Psychotic Disorders: findings from the B-SNIP Study

    OPEN Citation: Transl Psychiatry (2017) 7, e1249; doi:10.1038/tp.2017.210 www.nature.com/tp ORIGINAL ARTICLE Genome-wide association studies of smooth pursuit and antisaccade eye movements in psychotic disorders: findings from the B-SNIP study R Lencer1, LJ Mills2, N Alliey-Rodriguez3, R Shafee4,5,AMLee6, JL Reilly7, A Sprenger8, JE McDowell9, SA McCarroll4, MS Keshavan10, GD Pearlson11,12, CA Tamminga13, BA Clementz9, ES Gershon3, JA Sweeney13,14 and JR Bishop6,15 Eye movement deviations, particularly deficits of initial sensorimotor processing and sustained pursuit maintenance, and antisaccade inhibition errors, are established intermediate phenotypes for psychotic disorders. We here studied eye movement measures of 849 participants from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study (schizophrenia N = 230, schizoaffective disorder N = 155, psychotic bipolar disorder N = 206 and healthy controls N = 258) as quantitative phenotypes in relation to genetic data, while controlling for genetically derived ancestry measures, age and sex. A mixed-modeling genome-wide association studies approach was used including ~ 4.4 million genotypes (PsychChip and 1000 Genomes imputation). Across participants, sensorimotor processing at pursuit initiation was significantly associated with a single nucleotide polymorphism in IPO8 (12p11.21, P =8×10− 11), whereas suggestive associations with sustained pursuit maintenance were identified with SNPs in SH3GL2 (9p22.2, P =3×10− 8). In participants of predominantly African ancestry, sensorimotor processing was also significantly associated with SNPs in PCDH12 (5q31.3, P = 1.6 × 10 − 10), and suggestive associations were observed with NRSN1 (6p22.3, P = 5.4 × 10 −8) and LMO7 (13q22.2, P = 7.3x10−8), whereas antisaccade error rate was significantly associated with a non-coding region at chromosome 7 (P = 6.5 × 10− 9).
  • Dyslexia Risk Variant Rs600753 Is Linked with Dyslexia-Specific Differential Allelic Expression of DYX1C1

    Dyslexia Risk Variant Rs600753 Is Linked with Dyslexia-Specific Differential Allelic Expression of DYX1C1

    Genetics and Molecular Biology, 41, 1, 41-49 (2018) Copyright © 2018, Sociedade Brasileira de Genética. Printed in Brazil DOI: http://dx.doi.org/10.1590/1678-4685-GMB-2017-0165 Research Article Dyslexia risk variant rs600753 is linked with dyslexia-specific differential allelic expression of DYX1C1 Bent Müller1*, Johannes Boltze2,3*, Ivonne Czepezauer1, Volker Hesse4,5, LEGASCREEN Consortium, Arndt Wilcke1* and Holger Kirsten1,6,7* 1Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany. 2Fraunhofer Research Institution for Marine Biotechnology, Department of Medical Cell Technology, Lübeck, Germany. 3Institute for Medical and Marine Biotechnology, University of Lübeck, Lübeck, Germany. 4German Center for Growth, Development and Health Encouragement in Childhood and Adolescence, Berlin, Germany. 5Charité-University Medicine Berlin, Institute for Experimental Paediatric Endocrinolgy, Berlin, 6Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany. 7LIFE - Leipzig Research Center for Civilization Diseases, University of Leipzig, Leipzig, Germany. Abstract An increasing number of genetic variants involved in dyslexia development were discovered during the last years, yet little is known about the molecular functional mechanisms of these SNPs. In this study we investigated whether dyslexia candidate SNPs have a direct, disease-specific effect on local expression levels of the assumed target gene by using a differential allelic expression assay. In total, 12 SNPs previously associated with dyslexia and related phe- notypes were suitable for analysis. Transcripts corresponding to four SNPs were sufficiently expressed in 28 cell lines originating from controls and a family affected by dyslexia. We observed a significant effect of rs600753 on ex- pression levels of DYX1C1 in forward and reverse sequencing approaches.
  • PARP Inhibition Suppresses GR–MYCN–CDK5– RB1–E2F1

    PARP Inhibition Suppresses GR–MYCN–CDK5– RB1–E2F1

    Published OnlineFirst August 22, 2019; DOI: 10.1158/1078-0432.CCR-19-0317 Translational Cancer Mechanisms and Therapy Clinical Cancer Research PARP Inhibition Suppresses GR–MYCN–CDK5– RB1–E2F1 Signaling and Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer Bo Liu1, Likun Li1, Guang Yang1, Chuandong Geng1, Yong Luo1, Wenhui Wu2, Ganiraju C. Manyam2, Dimitrios Korentzelos1, Sanghee Park1, Zhe Tang1, Cheng Wu1, Zhenyang Dong1, Michael Sigouros3, Andrea Sboner4,5,6, Himisha Beltran7, Yu Chen3,8,9, Paul G. Corn1, Michael T. Tetzlaff10, Patricia Troncoso10, Bradley Broom2, and Timothy C. Thompson1 Abstract Purpose: In this study, we addressed the underlying ing pathway that drives NED in prostatic adenocarcinoma mechanisms for the association between enzalutamide (ENZ) PDX and cell line models. Mechanistically, long-term treatment and neuroendocrine prostate cancer (NEPC), and ENZ treatment transcriptionally upregulates signaling of the critical involvement of MYCN, and loss of RB1 function in the GR–MYCN axis, leading to CDK5R1 and CDK5R2 upre- neuroendocrine differentiation (NED) of prostatic epithelial gulation, Rb1 phosphorylation, and N-Myc–mediated cells, and the development of NEPC. We further sought to and E2F1-mediated NED gene expression. Importantly, determine whether PARP inhibition could suppress NEPC, olaparib (OLA) or talazoparib (TALA) suppressed these and to identify molecular determinants of this therapeutic activities, and the combination of OLA and dinaciclib activity. (DINA), an inhibitor of CDK2 and CDK5, which also Experimental Design: We used a novel prostate cancer inhibits Rb1 phosphorylation, suppressed NED and signif- patient–derived xenograft (PDX) treatment model, prostatic icantly improved therapeutic efficiency in NEPC cells in vitro adenocarcinoma and NEPC cell lines, an NEPC organoid line, and in NEPC tumors in vivo.